Hugh Salamon
Hugh Salamon
Chief Executive Officer and Founder, Knowledge Synthesis Inc.
Verified email at knowledgesynthesis.com
Title
Cited by
Cited by
Year
Comparative genomics of BCG vaccines by whole-genome DNA microarray
MA Behr, MA Wilson, WP Gill, H Salamon, GK Schoolnik, S Rane, ...
Science 284 (5419), 1520-1523, 1999
20631999
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
MA Behr, SA Warren, H Salamon, PC Hopewell, AP De Leon, CL Daley, ...
The Lancet 353 (9151), 444-449, 1999
9851999
Comparing genomes within the species Mycobacterium tuberculosis
M Kato-Maeda, JT Rhee, TR Gingeras, H Salamon, J Drenkow, ...
Genome Research 11 (4), 547-554, 2001
3802001
Dynamic antibody responses to the Mycobacterium tuberculosis proteome
S Kunnath-Velayudhan, H Salamon, HY Wang, AL Davidow, DM Molina, ...
Proceedings of the National Academy of Sciences 107 (33), 14703-14708, 2010
2542010
Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs
L Shi, H Salamon, EA Eugenin, R Pine, A Cooper, ML Gennaro
Scientific reports 5 (1), 1-13, 2015
1182015
Cutting edge: vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection
H Salamon, N Bruiners, K Lakehal, L Shi, J Ravi, KD Yamaguchi, R Pine, ...
The Journal of Immunology 193 (1), 30-34, 2014
952014
Evolution of HLA class II molecules: allelic and amino acid site variability across populations
H Salamon, W Klitz, S Easteal, X Gao, HA Erlich, M Fernandez-Vina, ...
Genetics 152 (1), 393-400, 1999
851999
Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data
H Salamon, M Kato-Maeda, PM Small, J Drenkow, TR Gingeras
Genome research 10 (12), 2044-2054, 2000
792000
Proteome-Scale Antibody Responses and Outcome of Mycobacterium tuberculosis Infection in Nonhuman Primates and in Tuberculosis Patients
S Kunnath-Velayudhan, AL Davidow, HY Wang, DM Molina, VT Huynh, ...
Journal of Infectious Diseases 206 (5), 697-705, 2012
542012
Interferon-beta-1b-induced short-and long-term signatures of treatment activity in multiple sclerosis
E Croze, KD Yamaguchi, V Knappertz, AT Reder, H Salamon
The pharmacogenomics journal 13 (5), 443-451, 2013
532013
IFN-β 1b Induces Transient and Variable Gene Expression in Relapsing-Remitting Multiple Sclerosis Patients Independent of Neutralizing Antibodies or Changes in IFN Receptor RNAá…
AT Reder, S Velichko, KD Yamaguchi, K Hamamcioglu, K Ku, J Beekman, ...
Journal of Interferon & Cytokine Research 28 (5), 317-331, 2008
522008
Use of pulsed-field gel electrophoresis for molecular epidemiologic and population genetic studies ofMycobacterium tuberculosis
SP Singh, H Salamon, CJ Lahti, M Farid-Moyer, PM Small
Journal of clinical microbiology 37 (6), 1927-1931, 1999
501999
IFN-β-regulated genes show abnormal expression in therapy-na´ve relapsing–remitting MS mononuclear cells: Gene expression analysis employing all reported protein–proteiná…
KD Yamaguchi, DL Ruderman, E Croze, TC Wagner, S Velichko, ...
Journal of neuroimmunology 195 (1-2), 116-120, 2008
432008
The dynamics of repeated elements: applications to the epidemiology of tuberculosis
MM Tanaka, PM Small, H Salamon, MW Feldman
Proceedings of the National Academy of Sciences 97 (7), 3532-3537, 2000
382000
Integration of Published Information Into a Resistance-Associated Mutation Database for Mycobacterium tuberculosis
H Salamon, KD Yamaguchi, DM Cirillo, P Miotto, M Schito, J Posey, ...
The Journal of infectious diseases 211 (suppl_2), S50-S57, 2015
352015
Genetic distances for the study of infectious disease epidemiology
H Salamon, MA Behr, JT Rhee, PM Small
American journal of epidemiology 151 (3), 324-334, 2000
352000
Accommodating error analysis in comparison and clustering of molecular fingerprints.
H Salamon, MR Segal, AP de Leon, PM Small
Emerging infectious diseases 4 (2), 159, 1998
321998
Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific
V Guerrini, B Prideaux, L Blanc, N Bruiners, R Arrigucci, S Singh, ...
PLoS pathogens 14 (8), e1007223, 2018
312018
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice
JD Campbell, SA Kell, HM Kozy, JA Lum, R Sweetwood, M Chu, ...
Thorax 69 (6), 565-573, 2014
292014
Differential inhibition of inducible T cell cytokine secretion by potent iron chelators
S Leung, A Holbrook, B King, HT Lu, V Evans, N Miyamoto, C Mallari, ...
Journal of biomolecular screening 10 (2), 157-167, 2005
232005
The system can't perform the operation now. Try again later.
Articles 1–20